Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Disability-Adjusted Life-Years (Dalys) for 315 Diseases and Injuries and Healthy Life Expectancy (Hale) in Iran and Its Neighboring Countries, 1990–2015: Findings From Global Burden of Disease Study 2015
Fatemeh Nabavizadeh Rafsanjani
Fatemeh Nabavizadeh Rafsanjani

Professor of Physiology

Department Physiology

School of Medicine

Electrophysiology Research Center

Tehran University of Medical Sciences

All Documents
1. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
2. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)